Categories Analysis, Technology

Salesforce shifts to restructuring mode after a weak year. What to expect?

Operating cash flow rose to a record high in the fourth quarter when revenues increased across all business segments

After expanding constantly over the past decade, Salesforce.com Inc (NYSE: CRM) is currently focused on streamlining the business and increasing profitability. Like most tech firms, the software company is feeling the pinch of the dip in enterprise spending due to the Federal Reserve’s aggressive monetary policy stance and elevated inflation. The ongoing challenges have reversed the benefits of the widespread cloud adoption triggered by the pandemic, to some extent.    

The company’s stock got a major boost after this week’s impressive earnings report and it started Thursday’s session sharply higher. The good news is that the stock is projected to keep growing in the coming weeks and cross the $ 200 mark this year. For those looking for an appropriate entry point, probably now is the time to invest in Salesforce.

Reorganization

Though overall growth slowed last year, salesforce looks well-positioned to benefit from the thriving cloud market. The general slowdown in the tech sector, hurt by the economic downturn, has affected Salesforce also. The customer relationship management platform recently announced a restructuring program that would include a 10% reduction in its workforce and the closure of offices in certain markets, to better align the business with the changed market environment.

Salesforce Q4 2022 earnings infographic

The reorganization comes on the heels of two senior executives leaving the company in quick succession — co-chair and CEO Bret Taylor and Stewart Butterfield, CEO of Slack that joined the Salesforce fold a few years ago. When it comes to tackling external headwinds, the company’s balanced portfolio comes in handy. Since all business segments contribute almost equally to revenues, the ups and downs in a particular area do not materially impact the top line.

Outlook

Having entered the new fiscal year on a high note, the company predicts strong revenue and earnings performance for the first quarter and fiscal 2024. It ended 2023 with record-high cash flows of $7.1 billion, which is up 19% year-over-year. That will allow the management to return a portion of the cash to shareholders in the form of share buybacks and dividends.

From Salesforce’s Q4 2023 earnings conference call:

As we entered our fourth quarter, we recognized that we need to radically accelerate the transformation plan time frame. We needed to press the hyperSpace button and bring the two-year goals forward quickly and exceed them now. We immediately put into place an accelerated transformation plan in four areas; short-term and long-term restructuring of the company, improving profitability and productivity, prioritizing our core innovations, and a deeper and even stronger relationship with our shareholders.

Q4 Outcome

Fourth-quarter profit exceeded analysts’ forecast, continuing the long-term trend of consistently beating or matching estimates. However, revenues missed the Street view despite increasing to $8.4 billion. All the operating segments and geographical divisions grew in double digits. Supported by the 14% revenue growth, adjusted earnings more than doubled to $1.68 per share.


Earnings Infographic: Oracle Q2 2023 revenue rises 18%


CRM traded sharply higher in the early hours of Thursday’s session, continuing the steady growth that began in the final weeks of 2022. It has gained a whopping 42% so far this year.

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Comments

  1. Thank you for this informative blog post!
    Salesforce is seeing pressure from the Federal Reserve’s aggressive monetary policy stance and increased inflation. The company is reorganizing to face these challenges, and is projected to earn strong profits in the coming years.
    Wayne

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top